A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: Stereotactic ablative radiotherapy or external beam + high dose rate brachytherapy boost

Patients treated with HDR-boost reported deterioration of QOL particularly in sexual domains in comparison with SABR.